Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed COO
|
|
MyoKardia, Inc. (MYOK)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/27/2020 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 11/27/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/24/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/24/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/24/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/24/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/24/2020 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 11/19/2020 |
4
| Meeker David P (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 4,100 shares
@ $0
Disposed/sold 22,000 options to buy
@ $11.55, valued at
$254.1k
Disposed/sold 11,000 options to buy
@ $14, valued at
$154k
Disposed/sold 11,000 options to buy
@ $48.85, valued at
$537.4k
Disposed/sold 6,600 options to buy
@ $47.77, valued at
$315.3k
Disposed/sold 3,000 options to buy
@ $100.27, valued at
$300.8k
|
|
| 11/19/2020 |
4
| McDowell Robert Scott (Chief Scientific Officer) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 36,616 shares
@ $0
Disposed/sold 87,074 options to buy
@ $0.1838, valued at
$16k
Disposed/sold 40,816 options to buy
@ $0.3308, valued at
$13.5k
Disposed/sold 36,735 options to buy
@ $1.5068, valued at
$55.4k
Disposed/sold 27,211 options to buy
@ $9.08, valued at
$247.1k
Disposed/sold 79,850 options to buy
@ $12.25, valued at
$978.2k
Disposed/sold 20,000 options to buy
@ $13.9, valued at
$278k
Disposed/sold 46,000 options to buy
@ $52, valued at
$2.4M
Disposed/sold 57,400 options to buy
@ $40.11, valued at
$2.3M
Disposed/sold 38,818 options to buy
@ $70.4, valued at
$2.7M
|
|
| 11/19/2020 |
4
| Harris Taylor C. (CFO) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 42,559 shares
@ $0
Disposed/sold 100,000 options to buy
@ $48.5, valued at
$4.9M
Disposed/sold 49,400 options to buy
@ $40.11, valued at
$2M
Disposed/sold 46,060 options to buy
@ $70.4, valued at
$3.2M
|
|
| 11/19/2020 |
4
| AGARWAL SUNIL (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 4,100 shares
@ $0
Disposed/sold 22,000 options to buy
@ $7.4, valued at
$162.8k
Disposed/sold 11,000 options to buy
@ $13.6, valued at
$149.6k
Disposed/sold 11,000 options to buy
@ $14, valued at
$154k
Disposed/sold 11,000 options to buy
@ $48.85, valued at
$537.4k
Disposed/sold 6,600 options to buy
@ $47.77, valued at
$315.3k
Disposed/sold 3,000 options to buy
@ $100.27, valued at
$300.8k
|
|
| 11/19/2020 |
4
| Fairey William (EVP, Chief Commercial Officer) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 42,199 shares
@ $0
Disposed/sold 69,500 options to buy
@ $40.99, valued at
$2.8M
Disposed/sold 39,022 options to buy
@ $70.4, valued at
$2.7M
|
|
| 11/19/2020 |
4
| Bauer Jake (Chief Business Officer) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 90,209 shares
@ $0
Disposed/sold 16,530 options to buy
@ $1.5068, valued at
$24.9k
Disposed/sold 8,748 options to buy
@ $9.08, valued at
$79.4k
Disposed/sold 35,150 options to buy
@ $12.25, valued at
$430.6k
Disposed/sold 57,400 options to buy
@ $40.11, valued at
$2.3M
Disposed/sold 34,000 options to buy
@ $52, valued at
$1.8M
Disposed/sold 45,193 options to buy
@ $70.4, valued at
$3.2M
|
|
| 11/19/2020 |
4
| PERRY MARK L (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 29,508 shares
@ $0
Disposed/sold 21,800 options to buy
@ $10, valued at
$218k
Disposed/sold 11,000 options to buy
@ $13.6, valued at
$149.6k
Disposed/sold 11,000 options to buy
@ $14, valued at
$154k
Disposed/sold 11,000 options to buy
@ $48.85, valued at
$537.4k
Disposed/sold 6,600 options to buy
@ $47.77, valued at
$315.3k
Disposed/sold 3,000 options to buy
@ $100.27, valued at
$300.8k
|
|
| 11/19/2020 |
4
| Popovits Kimberly J (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 4,100 shares
@ $0
Disposed/sold 22,000 options to buy
@ $14.35, valued at
$315.7k
Disposed/sold 11,000 options to buy
@ $14, valued at
$154k
Disposed/sold 11,000 options to buy
@ $48.85, valued at
$537.4k
Disposed/sold 6,600 options to buy
@ $47.77, valued at
$315.3k
Disposed/sold 3,000 options to buy
@ $100.27, valued at
$300.8k
|
|
| 11/19/2020 |
4
| CRANSTON MARY B (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 4,100 shares
@ $0
Disposed/sold 11,000 options to buy
@ $13.6, valued at
$149.6k
Disposed/sold 11,000 options to buy
@ $14, valued at
$154k
Disposed/sold 11,000 options to buy
@ $48.85, valued at
$537.4k
Disposed/sold 6,600 options to buy
@ $47.77, valued at
$315.3k
Disposed/sold 3,000 options to buy
@ $100.27, valued at
$300.8k
|
|
| 11/19/2020 |
4
| GIANAKAKOS ANASTASIOS (President and CEO) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 141,405 shares
@ $0
Unknown transaction of 129,407 shares
@ $0
Unknown transaction of 300,000 shares
@ $0
Unknown transaction of 7,000 shares
@ $0
Unknown transaction of 10,000 shares
@ $0
Unknown transaction of 53,087 shares
@ $0
Disposed/sold 149,517 options to buy
@ $1.5068, valued at
$225.3k
Disposed/sold 72,562 options to buy
@ $9.08, valued at
$658.9k
Disposed/sold 303,500 options to buy
@ $12.25, valued at
$3.7M
Disposed/sold 184,100 options to buy
@ $52, valued at
$9.6M
Disposed/sold 236,500 options to buy
@ $40.11, valued at
$9.5M
|
|
| 11/19/2020 |
4
| YARNO WENDY L (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 5,508 shares
@ $0
Disposed/sold 22,000 options to buy
@ $14.35, valued at
$315.7k
Disposed/sold 11,000 options to buy
@ $14, valued at
$154k
Disposed/sold 11,000 options to buy
@ $48.85, valued at
$537.4k
Disposed/sold 6,600 options to buy
@ $47.77, valued at
$315.3k
Disposed/sold 3,000 options to buy
@ $100.27, valued at
$300.8k
|
|
| 11/19/2020 |
4
| Waynick Denelle J (Chief Legal Officer) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 25,000 shares
@ $0
Disposed/sold 80,000 options to buy
@ $93.84, valued at
$7.5M
|
|
| 11/17/2020 |
8-K
| Resignation/termination of a director |
| 11/17/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 11/17/2020 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 11/17/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 11/15/2020 |
GN
| MyoKardia Presents Cardiac Imaging Data from 30-Week EXPLORER-HCM Study of Mavacamten |
| 11/13/2020 |
GN
| MyoKardia Presents Mavacamten Clinical and Non-Clinical Data at the American Heart Association's Scientific Sessions 2020 |
| 11/11/2020 |
GN
| MyoKardia Collaborates with the American College of Cardiology and PINNACLE/Veradigm to Launch Patient Registry of Hypertrophic Cardiomyopathy |
| 11/10/2020 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a 1.9% stake in MyoKardia Inc |
| 11/10/2020 |
SC 13G/A
| FMR LLC reports a 0% stake in MYOKARDIA INC |
| 11/10/2020 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a |
| 11/05/2020 |
10-Q
| Quarterly Report for the period ended September 30, 2020 |
| 11/05/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 11/05/2020 |
8-K
| Quarterly results |
| 11/05/2020 |
GN
| MyoKardia Reports Third Quarter 2020 Financial Results |
| 11/04/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
|
|
|